APO Research
Talk to an analyst

APO RESEARCH · REPORT

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Analysis and Forecast 2026-2032

22 December 2025203 pages

Choose your research edition.

Industry ResearchPorcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines include CAHIC, Agrovet, Bioveta, Boehringer Ingelheim, CAVAC, Ceva, DHN, Komipharm and MSD Animal Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines sales, projected growth trends, production technology, application and end-user industry.

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Company

CAHIC

Agrovet

Bioveta

Boehringer Ingelheim

CAVAC

Ceva

DHN

Komipharm

MSD Animal Health

Phibro Animal Health

PULILE

Ringpu Biology

Tecon

WINSUN

ChengDu Tecbond

Sino Pharm

Jinyu Bio-Technology

Qilu Animal

Zoetis

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Type

Live Vaccines

Killed Vaccines

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Application

Government Tender

Market Sales

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Live Vaccines Major Manufacturers Table 3. Killed Vaccines Major Manufacturers Table 4. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Government Tender Major Manufacturers Table 6. Market Sales Major Manufacturers Table 7. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends Table 8. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Drivers Table 9. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Opportunities and Challenges Table 10. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Restraints Table 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2021-2026) Table 15. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2027-2032) Table 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (m units) Table 17. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2021-2026) & (m units) Table 18. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2027-2032) & (m units) Table 19. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2021-2026) Table 20. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2027-2032) Table 21. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Manufacturers (2021-2026) Table 25. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price (US$/k unit) of Manufacturers (2021-2026) Table 26. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers, Product Type & Application Table 29. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2021-2026) Table 36. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2027-2032) Table 37. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type 2021 VS 2025 VS 2032 (m units) Table 38. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (m units) Table 39. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2027-2032) & (m units) Table 40. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2021-2026) Table 41. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2027-2032) Table 42. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2021-2026) & (US$/k unit) Table 43. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2027-2032) & (US$/k unit) Table 44. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2021-2026) Table 48. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2027-2032) Table 49. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application 2021 VS 2025 VS 2032 (m units) Table 50. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (m units) Table 51. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2027-2032) & (m units) Table 52. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2021-2026) Table 53. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2027-2032) Table 54. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2021-2026) & (US$/k unit) Table 55. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2027-2032) & (US$/k unit) Table 56. CAHIC Company Information Table 57. CAHIC Business Overview Table 58. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 59. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 60. CAHIC Recent Development Table 61. Agrovet Company Information Table 62. Agrovet Business Overview Table 63. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 64. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 65. Agrovet Recent Development Table 66. Bioveta Company Information Table 67. Bioveta Business Overview Table 68. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 69. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 70. Bioveta Recent Development Table 71. Boehringer Ingelheim Company Information Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 74. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 75. Boehringer Ingelheim Recent Development Table 76. CAVAC Company Information Table 77. CAVAC Business Overview Table 78. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 79. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 80. CAVAC Recent Development Table 81. Ceva Company Information Table 82. Ceva Business Overview Table 83. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 84. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 85. Ceva Recent Development Table 86. DHN Company Information Table 87. DHN Business Overview Table 88. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 89. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 90. DHN Recent Development Table 91. Komipharm Company Information Table 92. Komipharm Business Overview Table 93. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 94. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 95. Komipharm Recent Development Table 96. MSD Animal Health Company Information Table 97. MSD Animal Health Business Overview Table 98. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 99. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 100. MSD Animal Health Recent Development Table 101. Phibro Animal Health Company Information Table 102. Phibro Animal Health Business Overview Table 103. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 104. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 105. Phibro Animal Health Recent Development Table 106. PULILE Company Information Table 107. PULILE Business Overview Table 108. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 109. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 110. PULILE Recent Development Table 111. Ringpu Biology Company Information Table 112. Ringpu Biology Business Overview Table 113. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 114. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 115. Ringpu Biology Recent Development Table 116. Tecon Company Information Table 117. Tecon Business Overview Table 118. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 119. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 120. Tecon Recent Development Table 121. WINSUN Company Information Table 122. WINSUN Business Overview Table 123. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 124. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 125. WINSUN Recent Development Table 126. ChengDu Tecbond Company Information Table 127. ChengDu Tecbond Business Overview Table 128. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 129. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 130. ChengDu Tecbond Recent Development Table 131. Sino Pharm Company Information Table 132. Sino Pharm Business Overview Table 133. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 134. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 135. Sino Pharm Recent Development Table 136. Jinyu Bio-Technology Company Information Table 137. Jinyu Bio-Technology Business Overview Table 138. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 139. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 140. Jinyu Bio-Technology Recent Development Table 141. Qilu Animal Company Information Table 142. Qilu Animal Business Overview Table 143. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 144. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 145. Qilu Animal Recent Development Table 146. Zoetis Company Information Table 147. Zoetis Business Overview Table 148. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 149. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 150. Zoetis Recent Development Table 151. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 152. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 153. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (m units) Table 154. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2027-2032) & (m units) Table 155. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Type (2021-2026) & (US$/k unit) Table 156. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Type (2027-2032) & (US$/k unit) Table 157. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 158. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 159. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (m units) Table 160. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2027-2032) & (m units) Table 161. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Application (2021-2026) & (US$/k unit) Table 162. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Application (2027-2032) & (US$/k unit) Table 163. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (m units) Table 167. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 168. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2027-2032) & (m units) Table 169. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Country (2021-2026) & (US$/k unit) Table 170. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Country (2027-2032) & (US$/k unit) Table 171. United States Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 172. Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 173. Mexico Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 174. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 175. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 176. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (m units) Table 177. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2027-2032) & (m units) Table 178. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Type (2021-2026) & (US$/k unit) Table 179. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Type (2027-2032) & (US$/k unit) Table 180. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 181. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 182. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (m units) Table 183. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2027-2032) & (m units) Table 184. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Application (2021-2026) & (US$/k unit) Table 185. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Application (2027-2032) & (US$/k unit) Table 186. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (m units) Table 190. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 191. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2027-2032) & (m units) Table 192. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Country (2021-2026) & (US$/k unit) Table 193. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Country (2027-2032) & (US$/k unit) Table 194. Germany Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 195. France Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 196. U.K. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 197. Italy Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 198. Russia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 199. Spain Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 200. Netherlands Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 201. Switzerland Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 202. Sweden Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 203. Poland Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 204. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 205. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 206. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (m units) Table 207. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2027-2032) & (m units) Table 208. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Type (2021-2026) & (US$/k unit) Table 209. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Type (2027-2032) & (US$/k unit) Table 210. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 211. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 212. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (m units) Table 213. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2027-2032) & (m units) Table 214. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Application (2021-2026) & (US$/k unit) Table 215. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Application (2027-2032) & (US$/k unit) Table 216. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 217. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 218. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (m units) Table 219. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2027-2032) & (m units) Table 220. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Type (2021-2026) & (US$/k unit) Table 221. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Type (2027-2032) & (US$/k unit) Table 222. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 223. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 224. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (m units) Table 225. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2027-2032) & (m units) Table 226. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Application (2021-2026) & (US$/k unit) Table 227. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Application (2027-2032) & (US$/k unit) Table 228. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 230. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 231. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (m units) Table 232. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 233. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2027-2032) & (m units) Table 234. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Country (2021-2026) & (US$/k unit) Table 235. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Country (2027-2032) & (US$/k unit) Table 236. Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 237. South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 238. India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 239. Australia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 240. Taiwan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 241. Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 242. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 243. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 244. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (m units) Table 245. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2027-2032) & (m units) Table 246. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Type (2021-2026) & (US$/k unit) Table 247. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Type (2027-2032) & (US$/k unit) Table 248. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 249. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 250. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (m units) Table 251. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2027-2032) & (m units) Table 252. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Application (2021-2026) & (US$/k unit) Table 253. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Application (2027-2032) & (US$/k unit) Table 254. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 255. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 256. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 257. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (m units) Table 258. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 259. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2027-2032) & (m units) Table 260. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Country (2021-2026) & (US$/k unit) Table 261. SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Country (2027-2032) & (US$/k unit) Table 262. Brazil Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 263. Argentina Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 264. Chile Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 265. Colombia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 266. Peru Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 267. Saudi Arabia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 268. Israel Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 269. UAE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 270. Turkey Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 271. Iran Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 272. Egypt Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Table 273. Key Raw Materials Table 274. Raw Materials Key Suppliers Table 275. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors List Table 276. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers List Table 277. Research Programs/Design for This Report Table 278. Authors List of This Report Table 279. Secondary Sources Table 280. Primary Sources List of Figures Figure 1. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Image Figure 2. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Live Vaccines Image Figure 5. Killed Vaccines Image Figure 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Government Tender Image Figure 9. Market Sales Image Figure 10. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Figure 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2021-2032) Figure 15. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (2021-2032) & (m units) Figure 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2021 VS 2025 VS 2032 (m units) Figure 17. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales YoY (2021-2032) & (m units) Figure 19. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales YoY (2021-2032) & (m units) Figure 20. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales YoY (2021-2032) & (m units) Figure 21. Asia (Excluding China) Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales YoY (2021-2032) & (m units) Figure 22. South America, Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales YoY (2021-2032) & (m units) Figure 2

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Government Tender
  • Market Sales
Companies covered
  • CAHIC
  • Agrovet
  • Bioveta
  • Boehringer Ingelheim
  • CAVAC
  • Ceva
  • DHN
  • Komipharm
  • MSD Animal Health
  • Phibro Animal Health
  • PULILE
  • Ringpu Biology
  • Tecon
  • WINSUN
  • ChengDu Tecbond
  • Sino Pharm
  • Jinyu Bio-Technology
  • Qilu Animal
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Type
  3. 1.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Live Vaccines
  5. 1.2.3 Killed Vaccines
  6. 1.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Application
  7. 1.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Government Tender
  9. 1.3.3 Market Sales
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Dynamics
  1. 2.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends
  2. 2.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Drivers
  3. 2.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Opportunities and Challenges
  4. 2.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region
  3. 3.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region
  9. 3.4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Manufacturers
  6. 4.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Tier 1, Tier 2, and Tier 3
5 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Type
  1. 5.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type
  2. 5.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type
  6. 5.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2032) & (m units)
  8. 5.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type
6 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Application
  1. 6.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application
  2. 6.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application
  6. 6.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2032) & (m units)
  8. 6.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application
7 Company Profiles
  1. 7.1 CAHIC
  2. 7.1.1 CAHIC Company Information
  3. 7.1.2 CAHIC Business Overview
  4. 7.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  6. 7.1.5 CAHIC Recent Developments
  7. 7.2 Agrovet
  8. 7.2.1 Agrovet Company Information
  9. 7.2.2 Agrovet Business Overview
  10. 7.2.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  12. 7.2.5 Agrovet Recent Developments
  13. 7.3 Bioveta
  14. 7.3.1 Bioveta Company Information
  15. 7.3.2 Bioveta Business Overview
  16. 7.3.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  18. 7.3.5 Bioveta Recent Developments
  19. 7.4 Boehringer Ingelheim
  20. 7.4.1 Boehringer Ingelheim Company Information
  21. 7.4.2 Boehringer Ingelheim Business Overview
  22. 7.4.3 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  24. 7.4.5 Boehringer Ingelheim Recent Developments
  25. 7.5 CAVAC
  26. 7.5.1 CAVAC Company Information
  27. 7.5.2 CAVAC Business Overview
  28. 7.5.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  30. 7.5.5 CAVAC Recent Developments
  31. 7.6 Ceva
  32. 7.6.1 Ceva Company Information
  33. 7.6.2 Ceva Business Overview
  34. 7.6.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  36. 7.6.5 Ceva Recent Developments
  37. 7.7 DHN
  38. 7.7.1 DHN Company Information
  39. 7.7.2 DHN Business Overview
  40. 7.7.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  42. 7.7.5 DHN Recent Developments
  43. 7.8 Komipharm
  44. 7.8.1 Komipharm Company Information
  45. 7.8.2 Komipharm Business Overview
  46. 7.8.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  48. 7.8.5 Komipharm Recent Developments
  49. 7.9 MSD Animal Health
  50. 7.9.1 MSD Animal Health Company Information
  51. 7.9.2 MSD Animal Health Business Overview
  52. 7.9.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  54. 7.9.5 MSD Animal Health Recent Developments
  55. 7.10 Phibro Animal Health
  56. 7.10.1 Phibro Animal Health Company Information
  57. 7.10.2 Phibro Animal Health Business Overview
  58. 7.10.3 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  60. 7.10.5 Phibro Animal Health Recent Developments
  61. 7.11 PULILE
  62. 7.11.1 PULILE Company Information
  63. 7.11.2 PULILE Business Overview
  64. 7.11.3 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  66. 7.11.5 PULILE Recent Developments
  67. 7.12 Ringpu Biology
  68. 7.12.1 Ringpu Biology Company Information
  69. 7.12.2 Ringpu Biology Business Overview
  70. 7.12.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  72. 7.12.5 Ringpu Biology Recent Developments
  73. 7.13 Tecon
  74. 7.13.1 Tecon Company Information
  75. 7.13.2 Tecon Business Overview
  76. 7.13.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  78. 7.13.5 Tecon Recent Developments
  79. 7.14 WINSUN
  80. 7.14.1 WINSUN Company Information
  81. 7.14.2 WINSUN Business Overview
  82. 7.14.3 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  84. 7.14.5 WINSUN Recent Developments
  85. 7.15 ChengDu Tecbond
  86. 7.15.1 ChengDu Tecbond Company Information
  87. 7.15.2 ChengDu Tecbond Business Overview
  88. 7.15.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  90. 7.15.5 ChengDu Tecbond Recent Developments
  91. 7.16 Sino Pharm
  92. 7.16.1 Sino Pharm Company Information
  93. 7.16.2 Sino Pharm Business Overview
  94. 7.16.3 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  96. 7.16.5 Sino Pharm Recent Developments
  97. 7.17 Jinyu Bio-Technology
  98. 7.17.1 Jinyu Bio-Technology Company Information
  99. 7.17.2 Jinyu Bio-Technology Business Overview
  100. 7.17.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  102. 7.17.5 Jinyu Bio-Technology Recent Developments
  103. 7.18 Qilu Animal
  104. 7.18.1 Qilu Animal Company Information
  105. 7.18.2 Qilu Animal Business Overview
  106. 7.18.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  108. 7.18.5 Qilu Animal Recent Developments
  109. 7.19 Zoetis
  110. 7.19.1 Zoetis Company Information
  111. 7.19.2 Zoetis Business Overview
  112. 7.19.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  114. 7.19.5 Zoetis Recent Developments
8 North America
  1. 8.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
  2. 8.1.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2021-2032)
  5. 8.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
  6. 8.2.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2021-2032)
  9. 8.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
  10. 8.3.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
  2. 9.1.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
  6. 9.2.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
  10. 9.3.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
  2. 10.1.1 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2021-2032)
  5. 10.2 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
  6. 10.2.1 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
  2. 11.1.1 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
  6. 11.2.1 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
  10. 11.3.1 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
  2. 12.1.1 SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
  6. 12.2.1 SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
  10. 12.3.1 SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Value Chain Analysis
  2. 13.1.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Mode & Process
  6. 13.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors
  9. 13.2.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst